NEW YORK, Sept. 21, 2022 (GLOBE NEWSWIRE) — Immunovant, Inc. (Nasdaq: IMVT), a clinical-stage biopharmaceutical company committed to enabling normal lives for people with autoimmune diseases, today announced that Pete Salzmann, M.D., Chief Executive Officer, will present a corporate update at Roivant’s Investor Day, taking place on September 28th, 2022.
| Roivant Investor Day presentation details: | |
| Date: | Wednesday, September 28th, 2022 |
| Time: | 11:15 am Eastern Time |
| Webcast: | The presentation will be available via webcast and can be accessed at the Investor Relations section of the Company’s website, located at www.immunovant.com. |
About Immunovant, Inc.
Immunovant, Inc. is a clinical-stage biopharmaceutical company dedicated to enabling normal lives for people with autoimmune diseases. As a leader in FcRn inhibitor technology, the Company is boldly developing innovative therapies for a range of debilitating autoimmune diseases with significant unmet patient needs. The Company’s investigational compound, batoclimab, is a novel, fully human, monoclonal antibody targeting the neonatal Fc receptor (FcRn). For additional information on the Company, please visit www.immunovant.com.
Contact:
Chau Cheng, PhD, MBA
VP Investor Relations
Immunovant, Inc.
info@immunovant.com
Publication of Independent Study Heightens Demand for UroShield ELMSFORD, N.Y.--(BUSINESS WIRE)--NanoVibronix, Inc. (NASDAQ: NAOV) (the…
LAGUNA HILLS, Calif.--(BUSINESS WIRE)--Adagio Medical (Nasdaq: ADGM), a leading innovator in catheter ablation technologies for…
LAGUNA HILLS, Calif.--(BUSINESS WIRE)--Adagio Medical (Nasdaq: ADGM), a leading innovator in catheter ablation technologies for…
Randomized trial at LSU Health Shreveport will evaluate Seraph 100 Blood Filter's effectiveness in treating…
Stride Expands Across the Midwest, Celebrating its Tenth Center in Iowa and Sixth in Nebraska…
– FDA aligned on plan to initiate parallel Phase 2 trials of rademikibart in patients…
![](data:image/svg+xml;charset=utf-8,<svg height="32px" width="32px" xmlns="http://www.w3.org/2000/svg" version="1.1"/>)
![](data:image/svg+xml;charset=utf-8,<svg height="1px" width="1px" xmlns="http://www.w3.org/2000/svg" version="1.1"/>)
